Yong-Jun LIU

Dr. Liu is one of the world’s most prolific researchers in immunology, with over 80,617 citations (Google Scholar) and more than 260 published articles in top journals such as Nature and Science. He discovered the plasmacytoid dendritic cells (pDCs), a new cell type of the innate immune system, specialized in anti-viral immunity. His research has led to the development of several key drug targets in the areas of allergy, immunology and oncology. 

Dr. Liu received his doctor of medicine degree in 1984 from Norman Bethune University School of Medicine in China, and earned his doctorate in immunology in 1989 at the University of Birminghamin the U.K. Dr. Liu will be responsible for leading all of Sanofi’s research with the goal of delivering innovative and high-value medicines for patients. He will work in collaboration with Sanofi’s Senior Leadership Team to build a competitive R&D organization that leverages the best expertise, both internally and externally.